Reunió 20/10/2020
Mòduls no significatius (p>0.05 i <0.1)
Lípid de referencia: PI 36:1
Resultats PI 36:1 Tumor High vs Tumor Low
Cluster Sample
Determinació Beta
Cluster gens
Correlació mòduls i fenotips
Gens drivers dels mòduls associats al fenotip
GO
Es mostren els 10 millors GO
| X | module | size | p.val | Bonf | nInTerm | GO.id | ont | term.name |
|---|---|---|---|---|---|---|---|---|
| 1 | bisque4 | 47 | 9.5e-05 | 1.00 | 2 | GO:0044557 | BP | relaxation of smooth muscle |
| 2 | bisque4 | 47 | 9.5e-05 | 1.00 | 2 | GO:0060087 | BP | relaxation of vascular smooth muscle |
| 3 | bisque4 | 47 | 2.6e-04 | 1.00 | 2 | GO:0046600 | BP | negative regulation of centriole replication |
| 4 | bisque4 | 47 | 5.1e-04 | 1.00 | 2 | GO:0045986 | BP | negative regulation of smooth muscle contraction |
| 5 | bisque4 | 47 | 6.2e-04 | 1.00 | 2 | GO:0010826 | BP | negative regulation of centrosome duplication |
| 6 | bisque4 | 47 | 7.6e-04 | 1.00 | 10 | GO:0045321 | BP | leukocyte activation |
| 7 | bisque4 | 47 | 1.3e-03 | 1.00 | 7 | GO:0019901 | MF | protein kinase binding |
| 8 | bisque4 | 47 | 1.4e-03 | 1.00 | 2 | GO:0045932 | BP | negative regulation of muscle contraction |
| 9 | bisque4 | 47 | 1.7e-03 | 1.00 | 10 | GO:0001775 | BP | cell activation |
| 10 | bisque4 | 47 | 1.7e-03 | 1.00 | 7 | GO:0002366 | BP | leukocyte activation involved in immune response |
| 11 | black | 558 | 1.2e-03 | 1.00 | 6 | GO:0034405 | BP | response to fluid shear stress |
| 12 | black | 558 | 1.4e-03 | 1.00 | 2 | GO:0021570 | BP | rhombomere 4 development |
| 13 | black | 558 | 1.4e-03 | 1.00 | 2 | GO:0072368 | BP | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter |
| 14 | black | 558 | 1.4e-03 | 1.00 | 2 | GO:0102077 | MF | oleamide hydrolase activity |
| 15 | black | 558 | 1.4e-03 | 1.00 | 2 | GO:0103073 | MF | anandamide amidohydrolase activity |
| 16 | black | 558 | 2.3e-03 | 1.00 | 4 | GO:0042166 | MF | acetylcholine binding |
| 17 | black | 558 | 2.5e-03 | 1.00 | 6 | GO:0042304 | BP | regulation of fatty acid biosynthetic process |
| 18 | black | 558 | 2.9e-03 | 1.00 | 18 | GO:0001822 | BP | kidney development |
| 19 | black | 558 | 3.7e-03 | 1.00 | 4 | GO:0071498 | BP | cellular response to fluid shear stress |
| 20 | black | 558 | 4.0e-03 | 1.00 | 2 | GO:0035441 | BP | cell migration involved in vasculogenesis |
| 21 | blue | 751 | 3.7e-04 | 1.00 | 4 | GO:0038110 | BP | interleukin-2-mediated signaling pathway |
| 22 | blue | 751 | 6.4e-04 | 1.00 | 4 | GO:0071352 | BP | cellular response to interleukin-2 |
| 23 | blue | 751 | 1.0e-03 | 1.00 | 4 | GO:0070669 | BP | response to interleukin-2 |
| 24 | blue | 751 | 1.2e-03 | 1.00 | 5 | GO:0033962 | BP | cytoplasmic mRNA processing body assembly |
| 25 | blue | 751 | 1.5e-03 | 1.00 | 4 | GO:0030553 | MF | cGMP binding |
| 26 | blue | 751 | 2.2e-03 | 1.00 | 3 | GO:0008063 | BP | Toll signaling pathway |
| 27 | blue | 751 | 2.2e-03 | 1.00 | 4 | GO:0035325 | MF | Toll-like receptor binding |
| 28 | blue | 751 | 2.5e-03 | 1.00 | 2 | GO:0030221 | BP | basophil differentiation |
| 29 | blue | 751 | 2.5e-03 | 1.00 | 2 | GO:0051542 | BP | elastin biosynthetic process |
| 30 | blue | 751 | 2.5e-03 | 1.00 | 2 | GO:0004911 | MF | interleukin-2 receptor activity |
| 31 | brown | 635 | 2.3e-05 | 0.41 | 12 | GO:0015297 | MF | antiporter activity |
| 32 | brown | 635 | 2.4e-04 | 1.00 | 35 | GO:0010035 | BP | response to inorganic substance |
| 33 | brown | 635 | 3.3e-04 | 1.00 | 12 | GO:0007006 | BP | mitochondrial membrane organization |
| 34 | brown | 635 | 3.8e-04 | 1.00 | 6 | GO:0015301 | MF | anion:anion antiporter activity |
| 35 | brown | 635 | 5.3e-04 | 1.00 | 7 | GO:1901028 | BP | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
| 36 | brown | 635 | 6.2e-04 | 1.00 | 17 | GO:0045111 | CC | intermediate filament cytoskeleton |
| 37 | brown | 635 | 6.2e-04 | 1.00 | 33 | GO:0009636 | BP | response to toxic substance |
| 38 | brown | 635 | 7.2e-04 | 1.00 | 10 | GO:0072332 | BP | intrinsic apoptotic signaling pathway by p53 class mediator |
| 39 | brown | 635 | 1.1e-03 | 1.00 | 18 | GO:0015291 | MF | secondary active transmembrane transporter activity |
| 40 | brown | 635 | 1.2e-03 | 1.00 | 4 | GO:0042407 | BP | cristae formation |
| 41 | brown4 | 47 | 1.4e-04 | 1.00 | 2 | GO:0010873 | BP | positive regulation of cholesterol esterification |
| 42 | brown4 | 47 | 2.0e-04 | 1.00 | 2 | GO:0070471 | BP | uterine smooth muscle contraction |
| 43 | brown4 | 47 | 2.6e-04 | 1.00 | 2 | GO:0010872 | BP | regulation of cholesterol esterification |
| 44 | brown4 | 47 | 4.3e-04 | 1.00 | 5 | GO:0030258 | BP | lipid modification |
| 45 | brown4 | 47 | 6.2e-04 | 1.00 | 2 | GO:0018158 | BP | protein oxidation |
| 46 | brown4 | 47 | 6.2e-04 | 1.00 | 2 | GO:0034435 | BP | cholesterol esterification |
| 47 | brown4 | 47 | 8.5e-04 | 1.00 | 2 | GO:0030676 | MF | Rac guanyl-nucleotide exchange factor activity |
| 48 | brown4 | 47 | 1.7e-03 | 1.00 | 2 | GO:0010874 | BP | regulation of cholesterol efflux |
| 49 | brown4 | 47 | 1.7e-03 | 1.00 | 4 | GO:0017038 | BP | protein import |
| 50 | brown4 | 47 | 2.1e-03 | 1.00 | 2 | GO:0034369 | BP | plasma lipoprotein particle remodeling |
| 51 | cyan | 267 | 1.9e-04 | 1.00 | 3 | GO:0061072 | BP | iris morphogenesis |
| 52 | cyan | 267 | 9.4e-04 | 1.00 | 2 | GO:0035060 | CC | brahma complex |
| 53 | cyan | 267 | 3.1e-03 | 1.00 | 2 | GO:0097422 | CC | tubular endosome |
| 54 | cyan | 267 | 3.1e-03 | 1.00 | 2 | GO:0070569 | MF | uridylyltransferase activity |
| 55 | cyan | 267 | 6.3e-03 | 1.00 | 2 | GO:0032347 | BP | regulation of aldosterone biosynthetic process |
| 56 | cyan | 267 | 6.3e-03 | 1.00 | 2 | GO:0048840 | BP | otolith development |
| 57 | cyan | 267 | 6.3e-03 | 1.00 | 2 | GO:0061303 | BP | cornea development in camera-type eye |
| 58 | cyan | 267 | 6.3e-03 | 1.00 | 2 | GO:2000253 | BP | positive regulation of feeding behavior |
| 59 | cyan | 267 | 8.3e-03 | 1.00 | 2 | GO:0031053 | BP | primary miRNA processing |
| 60 | cyan | 267 | 8.8e-03 | 1.00 | 11 | GO:0032984 | BP | protein-containing complex disassembly |
| 61 | darkgreen | 181 | 4.5e-04 | 1.00 | 3 | GO:0070593 | BP | dendrite self-avoidance |
| 62 | darkgreen | 181 | 1.0e-03 | 1.00 | 3 | GO:0070262 | BP | peptidyl-serine dephosphorylation |
| 63 | darkgreen | 181 | 1.4e-03 | 1.00 | 2 | GO:2000002 | BP | negative regulation of DNA damage checkpoint |
| 64 | darkgreen | 181 | 1.7e-03 | 1.00 | 13 | GO:0061564 | BP | axon development |
| 65 | darkgreen | 181 | 2.3e-03 | 1.00 | 4 | GO:0016279 | MF | protein-lysine N-methyltransferase activity |
| 66 | darkgreen | 181 | 2.4e-03 | 1.00 | 4 | GO:0016278 | MF | lysine N-methyltransferase activity |
| 67 | darkgreen | 181 | 3.1e-03 | 1.00 | 32 | GO:0010628 | BP | positive regulation of gene expression |
| 68 | darkgreen | 181 | 3.3e-03 | 1.00 | 3 | GO:0045948 | BP | positive regulation of translational initiation |
| 69 | darkgreen | 181 | 3.9e-03 | 1.00 | 2 | GO:0010501 | BP | RNA secondary structure unwinding |
| 70 | darkgreen | 181 | 3.9e-03 | 1.00 | 2 | GO:0046974 | MF | histone methyltransferase activity (H3-K9 specific) |
| 71 | darkgrey | 169 | 1.3e-04 | 1.00 | 2 | GO:0004794 | MF | L-threonine ammonia-lyase activity |
| 72 | darkgrey | 169 | 3.9e-04 | 1.00 | 2 | GO:0006567 | BP | threonine catabolic process |
| 73 | darkgrey | 169 | 3.9e-04 | 1.00 | 2 | GO:0019518 | BP | L-threonine catabolic process to glycine |
| 74 | darkgrey | 169 | 3.9e-04 | 1.00 | 2 | GO:0003941 | MF | L-serine ammonia-lyase activity |
| 75 | darkgrey | 169 | 1.3e-03 | 1.00 | 2 | GO:0006526 | BP | arginine biosynthetic process |
| 76 | darkgrey | 169 | 1.3e-03 | 1.00 | 2 | GO:0006565 | BP | L-serine catabolic process |
| 77 | darkgrey | 169 | 1.3e-03 | 1.00 | 2 | GO:0006566 | BP | threonine metabolic process |
| 78 | darkgrey | 169 | 1.3e-03 | 1.00 | 2 | GO:0098684 | CC | photoreceptor ribbon synapse |
| 79 | darkgrey | 169 | 1.3e-03 | 1.00 | 7 | GO:0006338 | BP | chromatin remodeling |
| 80 | darkgrey | 169 | 1.9e-03 | 1.00 | 2 | GO:0009820 | BP | alkaloid metabolic process |
| 81 | darkmagenta | 72 | 7.2e-05 | 1.00 | 8 | GO:0032259 | BP | methylation |
| 82 | darkmagenta | 72 | 2.0e-04 | 1.00 | 6 | GO:0008168 | MF | methyltransferase activity |
| 83 | darkmagenta | 72 | 6.4e-04 | 1.00 | 2 | GO:0008401 | MF | retinoic acid 4-hydroxylase activity |
| 84 | darkmagenta | 72 | 1.3e-03 | 1.00 | 3 | GO:0051568 | BP | histone H3-K4 methylation |
| 85 | darkmagenta | 72 | 1.5e-03 | 1.00 | 2 | GO:0070166 | BP | enamel mineralization |
| 86 | darkmagenta | 72 | 1.8e-03 | 1.00 | 2 | GO:0080182 | BP | histone H3-K4 trimethylation |
| 87 | darkmagenta | 72 | 1.8e-03 | 1.00 | 2 | GO:0008391 | MF | arachidonic acid monooxygenase activity |
| 88 | darkmagenta | 72 | 1.8e-03 | 1.00 | 2 | GO:0008392 | MF | arachidonic acid epoxygenase activity |
| 89 | darkmagenta | 72 | 2.4e-03 | 1.00 | 4 | GO:0042737 | BP | drug catabolic process |
| 90 | darkmagenta | 72 | 2.7e-03 | 1.00 | 2 | GO:0019373 | BP | epoxygenase P450 pathway |
| 91 | darkolivegreen | 77 | 4.3e-03 | 1.00 | 4 | GO:0010212 | BP | response to ionizing radiation |
| 92 | darkolivegreen | 77 | 4.7e-03 | 1.00 | 3 | GO:0072422 | BP | signal transduction involved in DNA damage checkpoint |
| 93 | darkolivegreen | 77 | 4.8e-03 | 1.00 | 2 | GO:0048027 | MF | mRNA 5’-UTR binding |
| 94 | darkolivegreen | 77 | 4.9e-03 | 1.00 | 3 | GO:0072395 | BP | signal transduction involved in cell cycle checkpoint |
| 95 | darkolivegreen | 77 | 5.2e-03 | 1.00 | 1 | GO:0007495 | BP | visceral mesoderm-endoderm interaction involved in midgut development |
| 96 | darkolivegreen | 77 | 5.2e-03 | 1.00 | 1 | GO:0033301 | BP | cell cycle comprising mitosis without cytokinesis |
| 97 | darkolivegreen | 77 | 5.2e-03 | 1.00 | 1 | GO:0034059 | BP | response to anoxia |
| 98 | darkolivegreen | 77 | 5.2e-03 | 1.00 | 1 | GO:0061586 | BP | positive regulation of transcription by transcription factor localization |
| 99 | darkolivegreen | 77 | 5.2e-03 | 1.00 | 1 | GO:0071454 | BP | cellular response to anoxia |
| 100 | darkolivegreen | 77 | 5.2e-03 | 1.00 | 1 | GO:0072249 | BP | metanephric glomerular visceral epithelial cell development |
| 101 | darkorange | 156 | 1.7e-03 | 1.00 | 9 | GO:0015077 | MF | monovalent inorganic cation transmembrane transporter activity |
| 102 | darkorange | 156 | 2.1e-03 | 1.00 | 4 | GO:0046834 | BP | lipid phosphorylation |
| 103 | darkorange | 156 | 2.6e-03 | 1.00 | 2 | GO:0001527 | CC | microfibril |
| 104 | darkorange | 156 | 2.6e-03 | 1.00 | 2 | GO:0000774 | MF | adenyl-nucleotide exchange factor activity |
| 105 | darkorange | 156 | 3.4e-03 | 1.00 | 2 | GO:0044065 | BP | regulation of respiratory system process |
| 106 | darkorange | 156 | 3.5e-03 | 1.00 | 12 | GO:0008324 | MF | cation transmembrane transporter activity |
| 107 | darkorange | 156 | 4.6e-03 | 1.00 | 3 | GO:0060590 | MF | ATPase regulator activity |
| 108 | darkorange | 156 | 4.7e-03 | 1.00 | 11 | GO:0022890 | MF | inorganic cation transmembrane transporter activity |
| 109 | darkorange | 156 | 5.5e-03 | 1.00 | 5 | GO:0015079 | MF | potassium ion transmembrane transporter activity |
| 110 | darkorange | 156 | 5.5e-03 | 1.00 | 5 | GO:0015081 | MF | sodium ion transmembrane transporter activity |
| 111 | darkorange2 | 52 | 3.0e-04 | 1.00 | 8 | GO:0007264 | BP | small GTPase mediated signal transduction |
| 112 | darkorange2 | 52 | 4.3e-04 | 1.00 | 2 | GO:0010944 | BP | negative regulation of transcription by competitive promoter binding |
| 113 | darkorange2 | 52 | 6.6e-04 | 1.00 | 2 | GO:0046033 | BP | AMP metabolic process |
| 114 | darkorange2 | 52 | 1.3e-03 | 1.00 | 3 | GO:0019003 | MF | GDP binding |
| 115 | darkorange2 | 52 | 1.6e-03 | 1.00 | 4 | GO:0017137 | MF | Rab GTPase binding |
| 116 | darkorange2 | 52 | 1.7e-03 | 1.00 | 17 | GO:0035556 | BP | intracellular signal transduction |
| 117 | darkorange2 | 52 | 1.8e-03 | 1.00 | 3 | GO:0046332 | MF | SMAD binding |
| 118 | darkorange2 | 52 | 1.8e-03 | 1.00 | 2 | GO:0032925 | BP | regulation of activin receptor signaling pathway |
| 119 | darkorange2 | 52 | 2.4e-03 | 1.00 | 3 | GO:0045921 | BP | positive regulation of exocytosis |
| 120 | darkorange2 | 52 | 2.7e-03 | 1.00 | 2 | GO:0032400 | BP | melanosome localization |
| 121 | darkred | 190 | 4.7e-04 | 1.00 | 2 | GO:0005432 | MF | calcium:sodium antiporter activity |
| 122 | darkred | 190 | 5.7e-04 | 1.00 | 6 | GO:0043648 | BP | dicarboxylic acid metabolic process |
| 123 | darkred | 190 | 9.3e-04 | 1.00 | 2 | GO:0019556 | BP | histidine catabolic process to glutamate and formamide |
| 124 | darkred | 190 | 9.3e-04 | 1.00 | 2 | GO:0019557 | BP | histidine catabolic process to glutamate and formate |
| 125 | darkred | 190 | 9.3e-04 | 1.00 | 2 | GO:0106134 | BP | positive regulation of cardiac muscle cell contraction |
| 126 | darkred | 190 | 1.5e-03 | 1.00 | 2 | GO:0003062 | BP | regulation of heart rate by chemical signal |
| 127 | darkred | 190 | 1.5e-03 | 1.00 | 2 | GO:1901896 | BP | positive regulation of calcium-transporting ATPase activity |
| 128 | darkred | 190 | 2.0e-03 | 1.00 | 6 | GO:0009063 | BP | cellular amino acid catabolic process |
| 129 | darkred | 190 | 2.3e-03 | 1.00 | 2 | GO:0015942 | BP | formate metabolic process |
| 130 | darkred | 190 | 2.5e-03 | 1.00 | 3 | GO:0051560 | BP | mitochondrial calcium ion homeostasis |
| 131 | darkslateblue | 40 | 2.7e-03 | 1.00 | 1 | GO:0060683 | BP | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling |
| 132 | darkslateblue | 40 | 2.7e-03 | 1.00 | 1 | GO:1990401 | BP | embryonic lung development |
| 133 | darkslateblue | 40 | 2.7e-03 | 1.00 | 1 | GO:0008119 | MF | thiopurine S-methyltransferase activity |
| 134 | darkslateblue | 40 | 5.4e-03 | 1.00 | 1 | GO:0010512 | BP | negative regulation of phosphatidylinositol biosynthetic process |
| 135 | darkslateblue | 40 | 5.4e-03 | 1.00 | 1 | GO:0031443 | BP | fast-twitch skeletal muscle fiber contraction |
| 136 | darkslateblue | 40 | 5.4e-03 | 1.00 | 1 | GO:1905719 | BP | protein localization to perinuclear region of cytoplasm |
| 137 | darkslateblue | 40 | 5.4e-03 | 1.00 | 1 | GO:0044753 | CC | amphisome |
| 138 | darkslateblue | 40 | 5.4e-03 | 1.00 | 1 | GO:0060053 | CC | neurofilament cytoskeleton |
| 139 | darkslateblue | 40 | 6.0e-03 | 1.00 | 2 | GO:2001238 | BP | positive regulation of extrinsic apoptotic signaling pathway |
| 140 | darkslateblue | 40 | 8.1e-03 | 1.00 | 1 | GO:0035789 | BP | metanephric mesenchymal cell migration |
| 141 | darkturquoise | 177 | 5.7e-05 | 1.00 | 5 | GO:0043209 | CC | myelin sheath |
| 142 | darkturquoise | 177 | 6.3e-04 | 1.00 | 4 | GO:0019212 | MF | phosphatase inhibitor activity |
| 143 | darkturquoise | 177 | 1.5e-03 | 1.00 | 5 | GO:0019208 | MF | phosphatase regulator activity |
| 144 | darkturquoise | 177 | 2.5e-03 | 1.00 | 5 | GO:0046928 | BP | regulation of neurotransmitter secretion |
| 145 | darkturquoise | 177 | 2.6e-03 | 1.00 | 2 | GO:1900227 | BP | positive regulation of NLRP3 inflammasome complex assembly |
| 146 | darkturquoise | 177 | 3.2e-03 | 1.00 | 6 | GO:0048489 | BP | synaptic vesicle transport |
| 147 | darkturquoise | 177 | 3.7e-03 | 1.00 | 4 | GO:0032387 | BP | negative regulation of intracellular transport |
| 148 | darkturquoise | 177 | 4.3e-03 | 1.00 | 2 | GO:0019911 | MF | structural constituent of myelin sheath |
| 149 | darkturquoise | 177 | 4.7e-03 | 1.00 | 4 | GO:0019888 | MF | protein phosphatase regulator activity |
| 150 | darkturquoise | 177 | 5.4e-03 | 1.00 | 2 | GO:0006188 | BP | IMP biosynthetic process |
| 151 | floralwhite | 55 | 4.1e-05 | 0.75 | 2 | GO:0002081 | CC | outer acrosomal membrane |
| 152 | floralwhite | 55 | 2.9e-04 | 1.00 | 2 | GO:0072177 | BP | mesonephric duct development |
| 153 | floralwhite | 55 | 6.1e-04 | 1.00 | 2 | GO:0048096 | BP | chromatin-mediated maintenance of transcription |
| 154 | floralwhite | 55 | 1.0e-03 | 1.00 | 2 | GO:0042074 | BP | cell migration involved in gastrulation |
| 155 | floralwhite | 55 | 1.2e-03 | 1.00 | 2 | GO:2000095 | BP | regulation of Wnt signaling pathway, planar cell polarity pathway |
| 156 | floralwhite | 55 | 1.6e-03 | 1.00 | 2 | GO:0002080 | CC | acrosomal membrane |
| 157 | floralwhite | 55 | 1.8e-03 | 1.00 | 4 | GO:0090090 | BP | negative regulation of canonical Wnt signaling pathway |
| 158 | floralwhite | 55 | 2.5e-03 | 1.00 | 2 | GO:0002026 | BP | regulation of the force of heart contraction |
| 159 | floralwhite | 55 | 3.0e-03 | 1.00 | 2 | GO:2000050 | BP | regulation of non-canonical Wnt signaling pathway |
| 160 | floralwhite | 55 | 3.2e-03 | 1.00 | 5 | GO:0060070 | BP | canonical Wnt signaling pathway |
| 161 | green | 576 | 7.7e-04 | 1.00 | 4 | GO:0003157 | BP | endocardium development |
| 162 | green | 576 | 7.7e-04 | 1.00 | 4 | GO:0090266 | BP | regulation of mitotic cell cycle spindle assembly checkpoint |
| 163 | green | 576 | 1.3e-03 | 1.00 | 7 | GO:0030071 | BP | regulation of mitotic metaphase/anaphase transition |
| 164 | green | 576 | 1.4e-03 | 1.00 | 2 | GO:0021842 | BP | chemorepulsion involved in interneuron migration from the subpallium to the cortex |
| 165 | green | 576 | 1.4e-03 | 1.00 | 2 | GO:0099576 | BP | regulation of protein catabolic process at postsynapse, modulating synaptic transmission |
| 166 | green | 576 | 1.5e-03 | 1.00 | 7 | GO:0006998 | BP | nuclear envelope organization |
| 167 | green | 576 | 1.7e-03 | 1.00 | 3 | GO:0060956 | BP | endocardial cell differentiation |
| 168 | green | 576 | 1.7e-03 | 1.00 | 3 | GO:0090267 | BP | positive regulation of mitotic cell cycle spindle assembly checkpoint |
| 169 | green | 576 | 1.9e-03 | 1.00 | 23 | GO:0001701 | BP | in utero embryonic development |
| 170 | green | 576 | 1.9e-03 | 1.00 | 4 | GO:2000641 | BP | regulation of early endosome to late endosome transport |
| 171 | greenyellow | 296 | 1.7e-05 | 0.31 | 20 | GO:0031252 | CC | cell leading edge |
| 172 | greenyellow | 296 | 4.9e-05 | 0.90 | 11 | GO:0001890 | BP | placenta development |
| 173 | greenyellow | 296 | 1.7e-04 | 1.00 | 16 | GO:0031253 | CC | cell projection membrane |
| 174 | greenyellow | 296 | 2.3e-04 | 1.00 | 11 | GO:0001726 | CC | ruffle |
| 175 | greenyellow | 296 | 2.5e-04 | 1.00 | 5 | GO:0046621 | BP | negative regulation of organ growth |
| 176 | greenyellow | 296 | 4.6e-04 | 1.00 | 10 | GO:0031256 | CC | leading edge membrane |
| 177 | greenyellow | 296 | 6.2e-04 | 1.00 | 5 | GO:0048487 | MF | beta-tubulin binding |
| 178 | greenyellow | 296 | 6.4e-04 | 1.00 | 7 | GO:0001892 | BP | embryonic placenta development |
| 179 | greenyellow | 296 | 8.1e-04 | 1.00 | 7 | GO:0008080 | MF | N-acetyltransferase activity |
| 180 | greenyellow | 296 | 1.0e-03 | 1.00 | 7 | GO:0034333 | BP | adherens junction assembly |
| 181 | grey | 1200 | 3.9e-04 | 1.00 | 75 | GO:0016567 | BP | protein ubiquitination |
| 182 | grey | 1200 | 5.5e-04 | 1.00 | 5 | GO:0008020 | MF | G protein-coupled photoreceptor activity |
| 183 | grey | 1200 | 7.5e-04 | 1.00 | 14 | GO:0051117 | MF | ATPase binding |
| 184 | grey | 1200 | 8.0e-04 | 1.00 | 80 | GO:0032446 | BP | protein modification by small protein conjugation |
| 185 | grey | 1200 | 8.5e-04 | 1.00 | 42 | GO:0043062 | BP | extracellular structure organization |
| 186 | grey | 1200 | 1.4e-03 | 1.00 | 408 | GO:0019538 | BP | protein metabolic process |
| 187 | grey | 1200 | 1.5e-03 | 1.00 | 13 | GO:1905897 | BP | regulation of response to endoplasmic reticulum stress |
| 188 | grey | 1200 | 1.5e-03 | 1.00 | 5 | GO:0009881 | MF | photoreceptor activity |
| 189 | grey | 1200 | 2.3e-03 | 1.00 | 15 | GO:0032963 | BP | collagen metabolic process |
| 190 | grey | 1200 | 2.3e-03 | 1.00 | 8 | GO:0051294 | BP | establishment of spindle orientation |
| 191 | grey60 | 204 | 1.7e-04 | 1.00 | 2 | GO:0060160 | BP | negative regulation of dopamine receptor signaling pathway |
| 192 | grey60 | 204 | 2.2e-04 | 1.00 | 4 | GO:0051647 | BP | nucleus localization |
| 193 | grey60 | 204 | 3.6e-04 | 1.00 | 4 | GO:0019228 | BP | neuronal action potential |
| 194 | grey60 | 204 | 4.6e-04 | 1.00 | 5 | GO:0019226 | BP | transmission of nerve impulse |
| 195 | grey60 | 204 | 5.2e-04 | 1.00 | 2 | GO:0039689 | BP | negative stranded viral RNA replication |
| 196 | grey60 | 204 | 5.2e-04 | 1.00 | 2 | GO:0072709 | BP | cellular response to sorbitol |
| 197 | grey60 | 204 | 1.6e-03 | 1.00 | 3 | GO:0045061 | BP | thymic T cell selection |
| 198 | grey60 | 204 | 1.7e-03 | 1.00 | 2 | GO:0009052 | BP | pentose-phosphate shunt, non-oxidative branch |
| 199 | grey60 | 204 | 1.7e-03 | 1.00 | 2 | GO:0071569 | BP | protein ufmylation |
| 200 | grey60 | 204 | 1.7e-03 | 1.00 | 2 | GO:0072708 | BP | response to sorbitol |
| 201 | honeydew1 | 33 | 8.3e-04 | 1.00 | 2 | GO:0045956 | BP | positive regulation of calcium ion-dependent exocytosis |
| 202 | honeydew1 | 33 | 1.3e-03 | 1.00 | 3 | GO:0022843 | MF | voltage-gated cation channel activity |
| 203 | honeydew1 | 33 | 2.1e-03 | 1.00 | 2 | GO:1990573 | BP | potassium ion import across plasma membrane |
| 204 | honeydew1 | 33 | 2.2e-03 | 1.00 | 1 | GO:0001809 | BP | positive regulation of type IV hypersensitivity |
| 205 | honeydew1 | 33 | 2.2e-03 | 1.00 | 1 | GO:0070054 | BP | mRNA splicing, via endonucleolytic cleavage and ligation |
| 206 | honeydew1 | 33 | 2.2e-03 | 1.00 | 1 | GO:1990579 | BP | peptidyl-serine trans-autophosphorylation |
| 207 | honeydew1 | 33 | 2.2e-03 | 1.00 | 1 | GO:2000388 | BP | positive regulation of antral ovarian follicle growth |
| 208 | honeydew1 | 33 | 2.2e-03 | 1.00 | 1 | GO:0098683 | CC | cochlear hair cell ribbon synapse |
| 209 | honeydew1 | 33 | 2.2e-03 | 1.00 | 1 | GO:1990332 | CC | Ire1 complex |
| 210 | honeydew1 | 33 | 2.2e-03 | 1.00 | 1 | GO:1990630 | CC | IRE1-RACK1-PP2A complex |
| 211 | ivory | 53 | 2.5e-04 | 1.00 | 2 | GO:2000074 | BP | regulation of type B pancreatic cell development |
| 212 | ivory | 53 | 2.0e-03 | 1.00 | 2 | GO:0003323 | BP | type B pancreatic cell development |
| 213 | ivory | 53 | 2.7e-03 | 1.00 | 2 | GO:0006516 | BP | glycoprotein catabolic process |
| 214 | ivory | 53 | 3.2e-03 | 1.00 | 2 | GO:0002068 | BP | glandular epithelial cell development |
| 215 | ivory | 53 | 3.2e-03 | 1.00 | 2 | GO:0003309 | BP | type B pancreatic cell differentiation |
| 216 | ivory | 53 | 3.5e-03 | 1.00 | 1 | GO:0006431 | BP | methionyl-tRNA aminoacylation |
| 217 | ivory | 53 | 3.5e-03 | 1.00 | 1 | GO:0045081 | BP | negative regulation of interleukin-10 biosynthetic process |
| 218 | ivory | 53 | 3.5e-03 | 1.00 | 1 | GO:0004825 | MF | methionine-tRNA ligase activity |
| 219 | ivory | 53 | 3.5e-03 | 1.00 | 1 | GO:0004998 | MF | transferrin receptor activity |
| 220 | ivory | 53 | 3.8e-03 | 1.00 | 2 | GO:0035883 | BP | enteroendocrine cell differentiation |
| 221 | lavenderblush3 | 32 | 4.3e-04 | 1.00 | 2 | GO:0005892 | CC | acetylcholine-gated channel complex |
| 222 | lavenderblush3 | 32 | 2.1e-03 | 1.00 | 1 | GO:0001808 | BP | negative regulation of type IV hypersensitivity |
| 223 | lavenderblush3 | 32 | 2.1e-03 | 1.00 | 1 | GO:0006428 | BP | isoleucyl-tRNA aminoacylation |
| 224 | lavenderblush3 | 32 | 2.1e-03 | 1.00 | 1 | GO:1900370 | BP | positive regulation of RNA interference |
| 225 | lavenderblush3 | 32 | 2.1e-03 | 1.00 | 1 | GO:1900483 | BP | regulation of protein targeting to vacuolar membrane |
| 226 | lavenderblush3 | 32 | 2.1e-03 | 1.00 | 1 | GO:0003881 | MF | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity |
| 227 | lavenderblush3 | 32 | 2.1e-03 | 1.00 | 1 | GO:0004822 | MF | isoleucine-tRNA ligase activity |
| 228 | lavenderblush3 | 32 | 3.2e-03 | 1.00 | 3 | GO:0017137 | MF | Rab GTPase binding |
| 229 | lavenderblush3 | 32 | 3.4e-03 | 1.00 | 2 | GO:0000049 | MF | tRNA binding |
| 230 | lavenderblush3 | 32 | 3.6e-03 | 1.00 | 2 | GO:0031201 | CC | SNARE complex |
| 231 | lightcyan | 228 | 1.7e-04 | 1.00 | 7 | GO:0044070 | BP | regulation of anion transport |
| 232 | lightcyan | 228 | 3.6e-04 | 1.00 | 6 | GO:0030193 | BP | regulation of blood coagulation |
| 233 | lightcyan | 228 | 5.1e-04 | 1.00 | 3 | GO:0099558 | BP | maintenance of synapse structure |
| 234 | lightcyan | 228 | 5.8e-04 | 1.00 | 4 | GO:0010543 | BP | regulation of platelet activation |
| 235 | lightcyan | 228 | 5.8e-04 | 1.00 | 4 | GO:0072606 | BP | interleukin-8 secretion |
| 236 | lightcyan | 228 | 8.6e-04 | 1.00 | 3 | GO:0060766 | BP | negative regulation of androgen receptor signaling pathway |
| 237 | lightcyan | 228 | 1.1e-03 | 1.00 | 3 | GO:0034134 | BP | toll-like receptor 2 signaling pathway |
| 238 | lightcyan | 228 | 1.1e-03 | 1.00 | 6 | GO:2000379 | BP | positive regulation of reactive oxygen species metabolic process |
| 239 | lightcyan | 228 | 1.2e-03 | 1.00 | 11 | GO:0007599 | BP | hemostasis |
| 240 | lightcyan | 228 | 1.2e-03 | 1.00 | 19 | GO:0032870 | BP | cellular response to hormone stimulus |
| 241 | lightcyan1 | 59 | 5.2e-04 | 1.00 | 3 | GO:0018024 | MF | histone-lysine N-methyltransferase activity |
| 242 | lightcyan1 | 59 | 7.5e-04 | 1.00 | 5 | GO:0008514 | MF | organic anion transmembrane transporter activity |
| 243 | lightcyan1 | 59 | 7.9e-04 | 1.00 | 3 | GO:0016279 | MF | protein-lysine N-methyltransferase activity |
| 244 | lightcyan1 | 59 | 8.4e-04 | 1.00 | 3 | GO:0016278 | MF | lysine N-methyltransferase activity |
| 245 | lightcyan1 | 59 | 1.1e-03 | 1.00 | 3 | GO:0042054 | MF | histone methyltransferase activity |
| 246 | lightcyan1 | 59 | 1.8e-03 | 1.00 | 2 | GO:0015106 | MF | bicarbonate transmembrane transporter activity |
| 247 | lightcyan1 | 59 | 2.4e-03 | 1.00 | 3 | GO:0008276 | MF | protein methyltransferase activity |
| 248 | lightcyan1 | 59 | 3.1e-03 | 1.00 | 2 | GO:0048240 | BP | sperm capacitation |
| 249 | lightcyan1 | 59 | 3.5e-03 | 1.00 | 3 | GO:0008170 | MF | N-methyltransferase activity |
| 250 | lightcyan1 | 59 | 4.0e-03 | 1.00 | 1 | GO:0005986 | BP | sucrose biosynthetic process |
| 251 | lightgreen | 197 | 1.7e-04 | 1.00 | 2 | GO:0090119 | BP | vesicle-mediated cholesterol transport |
| 252 | lightgreen | 197 | 1.0e-03 | 1.00 | 9 | GO:0097237 | BP | cellular response to toxic substance |
| 253 | lightgreen | 197 | 1.2e-03 | 1.00 | 14 | GO:0048037 | MF | cofactor binding |
| 254 | lightgreen | 197 | 1.3e-03 | 1.00 | 7 | GO:0016705 | MF | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| 255 | lightgreen | 197 | 2.1e-03 | 1.00 | 3 | GO:0019865 | MF | immunoglobulin binding |
| 256 | lightgreen | 197 | 2.4e-03 | 1.00 | 2 | GO:1900004 | BP | negative regulation of serine-type endopeptidase activity |
| 257 | lightgreen | 197 | 2.4e-03 | 1.00 | 2 | GO:1902572 | BP | negative regulation of serine-type peptidase activity |
| 258 | lightgreen | 197 | 2.4e-03 | 1.00 | 2 | GO:0042587 | CC | glycogen granule |
| 259 | lightgreen | 197 | 2.7e-03 | 1.00 | 6 | GO:0020037 | MF | heme binding |
| 260 | lightgreen | 197 | 2.7e-03 | 1.00 | 5 | GO:0004497 | MF | monooxygenase activity |
| 261 | lightpink4 | 33 | 9.3e-05 | 1.00 | 2 | GO:0032027 | MF | myosin light chain binding |
| 262 | lightpink4 | 33 | 7.9e-04 | 1.00 | 3 | GO:0044773 | BP | mitotic DNA damage checkpoint |
| 263 | lightpink4 | 33 | 1.1e-03 | 1.00 | 3 | GO:0044774 | BP | mitotic DNA integrity checkpoint |
| 264 | lightpink4 | 33 | 1.1e-03 | 1.00 | 3 | GO:0030330 | BP | DNA damage response, signal transduction by p53 class mediator |
| 265 | lightpink4 | 33 | 1.4e-03 | 1.00 | 2 | GO:0048384 | BP | retinoic acid receptor signaling pathway |
| 266 | lightpink4 | 33 | 1.4e-03 | 1.00 | 4 | GO:0072331 | BP | signal transduction by p53 class mediator |
| 267 | lightpink4 | 33 | 1.8e-03 | 1.00 | 2 | GO:0030049 | BP | muscle filament sliding |
| 268 | lightpink4 | 33 | 1.8e-03 | 1.00 | 2 | GO:0033275 | BP | actin-myosin filament sliding |
| 269 | lightpink4 | 33 | 1.9e-03 | 1.00 | 3 | GO:0042770 | BP | signal transduction in response to DNA damage |
| 270 | lightpink4 | 33 | 1.9e-03 | 1.00 | 3 | GO:2000058 | BP | regulation of ubiquitin-dependent protein catabolic process |
| 271 | lightsteelblue1 | 59 | 1.1e-04 | 1.00 | 3 | GO:1903579 | BP | negative regulation of ATP metabolic process |
| 272 | lightsteelblue1 | 59 | 1.4e-04 | 1.00 | 3 | GO:0045980 | BP | negative regulation of nucleotide metabolic process |
| 273 | lightsteelblue1 | 59 | 1.2e-03 | 1.00 | 2 | GO:0090051 | BP | negative regulation of cell migration involved in sprouting angiogenesis |
| 274 | lightsteelblue1 | 59 | 1.5e-03 | 1.00 | 5 | GO:0072593 | BP | reactive oxygen species metabolic process |
| 275 | lightsteelblue1 | 59 | 1.6e-03 | 1.00 | 2 | GO:2001170 | BP | negative regulation of ATP biosynthetic process |
| 276 | lightsteelblue1 | 59 | 1.8e-03 | 1.00 | 2 | GO:0000715 | BP | nucleotide-excision repair, DNA damage recognition |
| 277 | lightsteelblue1 | 59 | 2.2e-03 | 1.00 | 3 | GO:0045454 | BP | cell redox homeostasis |
| 278 | lightsteelblue1 | 59 | 2.2e-03 | 1.00 | 3 | GO:0033143 | BP | regulation of intracellular steroid hormone receptor signaling pathway |
| 279 | lightsteelblue1 | 59 | 2.4e-03 | 1.00 | 5 | GO:0032868 | BP | response to insulin |
| 280 | lightsteelblue1 | 59 | 2.4e-03 | 1.00 | 4 | GO:2000377 | BP | regulation of reactive oxygen species metabolic process |
| 281 | lightyellow | 196 | 2.6e-04 | 1.00 | 4 | GO:0005865 | CC | striated muscle thin filament |
| 282 | lightyellow | 196 | 2.8e-04 | 1.00 | 8 | GO:0031461 | CC | cullin-RING ubiquitin ligase complex |
| 283 | lightyellow | 196 | 4.1e-04 | 1.00 | 3 | GO:0005523 | MF | tropomyosin binding |
| 284 | lightyellow | 196 | 6.8e-04 | 1.00 | 4 | GO:0031463 | CC | Cul3-RING ubiquitin ligase complex |
| 285 | lightyellow | 196 | 9.2e-04 | 1.00 | 8 | GO:0030017 | CC | sarcomere |
| 286 | lightyellow | 196 | 9.3e-04 | 1.00 | 7 | GO:0055002 | BP | striated muscle cell development |
| 287 | lightyellow | 196 | 1.6e-03 | 1.00 | 7 | GO:0055001 | BP | muscle cell development |
| 288 | lightyellow | 196 | 1.7e-03 | 1.00 | 8 | GO:0030016 | CC | myofibril |
| 289 | lightyellow | 196 | 2.3e-03 | 1.00 | 2 | GO:0051694 | BP | pointed-end actin filament capping |
| 290 | lightyellow | 196 | 2.3e-03 | 1.00 | 8 | GO:0043292 | CC | contractile fiber |
| 291 | magenta | 394 | 4.6e-04 | 1.00 | 5 | GO:0090218 | BP | positive regulation of lipid kinase activity |
| 292 | magenta | 394 | 5.5e-04 | 1.00 | 3 | GO:0001955 | BP | blood vessel maturation |
| 293 | magenta | 394 | 6.6e-04 | 1.00 | 2 | GO:0061102 | BP | stomach neuroendocrine cell differentiation |
| 294 | magenta | 394 | 6.6e-04 | 1.00 | 2 | GO:1990617 | CC | CHOP-ATF4 complex |
| 295 | magenta | 394 | 6.6e-04 | 1.00 | 2 | GO:0000171 | MF | ribonuclease MRP activity |
| 296 | magenta | 394 | 7.3e-04 | 1.00 | 8 | GO:0034644 | BP | cellular response to UV |
| 297 | magenta | 394 | 9.2e-04 | 1.00 | 5 | GO:0032994 | CC | protein-lipid complex |
| 298 | magenta | 394 | 9.5e-04 | 1.00 | 8 | GO:0032231 | BP | regulation of actin filament bundle assembly |
| 299 | magenta | 394 | 9.7e-04 | 1.00 | 6 | GO:0005778 | CC | peroxisomal membrane |
| 300 | magenta | 394 | 1.1e-03 | 1.00 | 12 | GO:0070507 | BP | regulation of microtubule cytoskeleton organization |
| 301 | maroon | 40 | 1.8e-03 | 1.00 | 2 | GO:0080025 | MF | phosphatidylinositol-3,5-bisphosphate binding |
| 302 | maroon | 40 | 2.6e-03 | 1.00 | 1 | GO:0006062 | BP | sorbitol catabolic process |
| 303 | maroon | 40 | 2.6e-03 | 1.00 | 1 | GO:0035752 | BP | lysosomal lumen pH elevation |
| 304 | maroon | 40 | 2.6e-03 | 1.00 | 1 | GO:0051160 | BP | L-xylitol catabolic process |
| 305 | maroon | 40 | 2.6e-03 | 1.00 | 1 | GO:0051164 | BP | L-xylitol metabolic process |
| 306 | maroon | 40 | 2.6e-03 | 1.00 | 1 | GO:0071602 | BP | phytosphingosine biosynthetic process |
| 307 | maroon | 40 | 2.6e-03 | 1.00 | 1 | GO:0000721 | MF | (R,R)-butanediol dehydrogenase activity |
| 308 | maroon | 40 | 2.6e-03 | 1.00 | 1 | GO:0003939 | MF | L-iditol 2-dehydrogenase activity |
| 309 | maroon | 40 | 2.6e-03 | 1.00 | 1 | GO:0004573 | MF | mannosyl-oligosaccharide glucosidase activity |
| 310 | maroon | 40 | 2.6e-03 | 1.00 | 1 | GO:0046526 | MF | D-xylulose reductase activity |
| 311 | mediumpurple3 | 59 | 9.0e-06 | 0.16 | 3 | GO:0051011 | MF | microtubule minus-end binding |
| 312 | mediumpurple3 | 59 | 1.7e-03 | 1.00 | 2 | GO:0070584 | BP | mitochondrion morphogenesis |
| 313 | mediumpurple3 | 59 | 1.9e-03 | 1.00 | 3 | GO:0046785 | BP | microtubule polymerization |
| 314 | mediumpurple3 | 59 | 3.6e-03 | 1.00 | 2 | GO:0007020 | BP | microtubule nucleation |
| 315 | mediumpurple3 | 59 | 3.9e-03 | 1.00 | 1 | GO:0021956 | BP | central nervous system interneuron axonogenesis |
| 316 | mediumpurple3 | 59 | 3.9e-03 | 1.00 | 1 | GO:0036071 | BP | N-glycan fucosylation |
| 317 | mediumpurple3 | 59 | 3.9e-03 | 1.00 | 1 | GO:0090226 | BP | regulation of microtubule nucleation by Ran protein signal transduction |
| 318 | mediumpurple3 | 59 | 3.9e-03 | 1.00 | 1 | GO:0098905 | BP | regulation of bundle of His cell action potential |
| 319 | mediumpurple3 | 59 | 3.9e-03 | 1.00 | 1 | GO:1901557 | BP | response to fenofibrate |
| 320 | mediumpurple3 | 59 | 3.9e-03 | 1.00 | 1 | GO:1901631 | BP | positive regulation of presynaptic membrane organization |
| 321 | midnightblue | 268 | 2.2e-05 | 0.41 | 3 | GO:0061156 | BP | pulmonary artery morphogenesis |
| 322 | midnightblue | 268 | 1.2e-04 | 1.00 | 4 | GO:0032331 | BP | negative regulation of chondrocyte differentiation |
| 323 | midnightblue | 268 | 2.4e-04 | 1.00 | 9 | GO:0048813 | BP | dendrite morphogenesis |
| 324 | midnightblue | 268 | 2.8e-04 | 1.00 | 8 | GO:0002062 | BP | chondrocyte differentiation |
| 325 | midnightblue | 268 | 3.7e-04 | 1.00 | 5 | GO:0032330 | BP | regulation of chondrocyte differentiation |
| 326 | midnightblue | 268 | 4.7e-04 | 1.00 | 4 | GO:0061037 | BP | negative regulation of cartilage development |
| 327 | midnightblue | 268 | 4.9e-04 | 1.00 | 8 | GO:1905477 | BP | positive regulation of protein localization to membrane |
| 328 | midnightblue | 268 | 5.4e-04 | 1.00 | 13 | GO:1903829 | BP | positive regulation of cellular protein localization |
| 329 | midnightblue | 268 | 8.7e-04 | 1.00 | 5 | GO:0009409 | BP | response to cold |
| 330 | midnightblue | 268 | 9.5e-04 | 1.00 | 2 | GO:0099575 | BP | regulation of protein catabolic process at presynapse, modulating synaptic transmission |
| 331 | navajowhite2 | 42 | 5.5e-04 | 1.00 | 2 | GO:0022840 | MF | leak channel activity |
| 332 | navajowhite2 | 42 | 1.3e-03 | 1.00 | 3 | GO:0035578 | CC | azurophil granule lumen |
| 333 | navajowhite2 | 42 | 1.7e-03 | 1.00 | 2 | GO:0071855 | MF | neuropeptide receptor binding |
| 334 | navajowhite2 | 42 | 2.6e-03 | 1.00 | 2 | GO:0019239 | MF | deaminase activity |
| 335 | navajowhite2 | 42 | 2.7e-03 | 1.00 | 1 | GO:1900148 | BP | negative regulation of Schwann cell migration |
| 336 | navajowhite2 | 42 | 2.7e-03 | 1.00 | 1 | GO:1903815 | BP | negative regulation of collecting lymphatic vessel constriction |
| 337 | navajowhite2 | 42 | 2.7e-03 | 1.00 | 1 | GO:1905045 | BP | negative regulation of Schwann cell proliferation involved in axon regeneration |
| 338 | navajowhite2 | 42 | 2.7e-03 | 1.00 | 1 | GO:0050277 | MF | sedoheptulokinase activity |
| 339 | navajowhite2 | 42 | 2.7e-03 | 1.00 | 1 | GO:0061768 | MF | magnesium:sodium antiporter activity |
| 340 | navajowhite2 | 42 | 3.8e-03 | 1.00 | 5 | GO:0015672 | BP | monovalent inorganic cation transport |
| 341 | orange | 150 | 5.7e-04 | 1.00 | 2 | GO:0004366 | MF | glycerol-3-phosphate O-acyltransferase activity |
| 342 | orange | 150 | 5.7e-04 | 1.00 | 2 | GO:0023024 | MF | MHC class I protein complex binding |
| 343 | orange | 150 | 5.7e-04 | 1.00 | 2 | GO:0102420 | MF | sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity |
| 344 | orange | 150 | 9.4e-04 | 1.00 | 2 | GO:0016584 | BP | nucleosome positioning |
| 345 | orange | 150 | 9.4e-04 | 1.00 | 2 | GO:0036021 | CC | endolysosome lumen |
| 346 | orange | 150 | 1.5e-03 | 1.00 | 4 | GO:0090181 | BP | regulation of cholesterol metabolic process |
| 347 | orange | 150 | 1.6e-03 | 1.00 | 5 | GO:0006641 | BP | triglyceride metabolic process |
| 348 | orange | 150 | 1.8e-03 | 1.00 | 3 | GO:0071108 | BP | protein K48-linked deubiquitination |
| 349 | orange | 150 | 2.0e-03 | 1.00 | 2 | GO:0006072 | BP | glycerol-3-phosphate metabolic process |
| 350 | orange | 150 | 2.1e-03 | 1.00 | 3 | GO:0035774 | BP | positive regulation of insulin secretion involved in cellular response to glucose stimulus |
| 351 | orangered4 | 65 | 5.3e-04 | 1.00 | 3 | GO:0008328 | CC | ionotropic glutamate receptor complex |
| 352 | orangered4 | 65 | 9.8e-04 | 1.00 | 2 | GO:0030207 | BP | chondroitin sulfate catabolic process |
| 353 | orangered4 | 65 | 1.4e-03 | 1.00 | 2 | GO:0004970 | MF | ionotropic glutamate receptor activity |
| 354 | orangered4 | 65 | 1.6e-03 | 1.00 | 2 | GO:0050655 | BP | dermatan sulfate proteoglycan metabolic process |
| 355 | orangered4 | 65 | 1.6e-03 | 1.00 | 2 | GO:0004549 | MF | tRNA-specific ribonuclease activity |
| 356 | orangered4 | 65 | 1.8e-03 | 1.00 | 2 | GO:0002902 | BP | regulation of B cell apoptotic process |
| 357 | orangered4 | 65 | 2.7e-03 | 1.00 | 2 | GO:0035235 | BP | ionotropic glutamate receptor signaling pathway |
| 358 | orangered4 | 65 | 3.0e-03 | 1.00 | 2 | GO:0008066 | MF | glutamate receptor activity |
| 359 | orangered4 | 65 | 3.3e-03 | 1.00 | 2 | GO:0001783 | BP | B cell apoptotic process |
| 360 | orangered4 | 65 | 3.3e-03 | 1.00 | 2 | GO:0032281 | CC | AMPA glutamate receptor complex |
| 361 | paleturquoise | 91 | 9.0e-04 | 1.00 | 11 | GO:0060322 | BP | head development |
| 362 | paleturquoise | 91 | 1.7e-03 | 1.00 | 7 | GO:0015631 | MF | tubulin binding |
| 363 | paleturquoise | 91 | 1.9e-03 | 1.00 | 2 | GO:0000235 | CC | astral microtubule |
| 364 | paleturquoise | 91 | 2.2e-03 | 1.00 | 3 | GO:2000179 | BP | positive regulation of neural precursor cell proliferation |
| 365 | paleturquoise | 91 | 2.3e-03 | 1.00 | 2 | GO:0007100 | BP | mitotic centrosome separation |
| 366 | paleturquoise | 91 | 2.7e-03 | 1.00 | 2 | GO:0051299 | BP | centrosome separation |
| 367 | paleturquoise | 91 | 2.9e-03 | 1.00 | 7 | GO:0030900 | BP | forebrain development |
| 368 | paleturquoise | 91 | 2.9e-03 | 1.00 | 4 | GO:0072686 | CC | mitotic spindle |
| 369 | paleturquoise | 91 | 4.0e-03 | 1.00 | 10 | GO:0000977 | MF | RNA polymerase II regulatory region sequence-specific DNA binding |
| 370 | paleturquoise | 91 | 4.2e-03 | 1.00 | 10 | GO:0001012 | MF | RNA polymerase II regulatory region DNA binding |
| 371 | palevioletred3 | 43 | 4.1e-04 | 1.00 | 14 | GO:0016787 | MF | hydrolase activity |
| 372 | palevioletred3 | 43 | 5.5e-04 | 1.00 | 3 | GO:0033116 | CC | endoplasmic reticulum-Golgi intermediate compartment membrane |
| 373 | palevioletred3 | 43 | 2.6e-03 | 1.00 | 3 | GO:0005793 | CC | endoplasmic reticulum-Golgi intermediate compartment |
| 374 | palevioletred3 | 43 | 2.6e-03 | 1.00 | 1 | GO:0002489 | BP | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent |
| 375 | palevioletred3 | 43 | 2.6e-03 | 1.00 | 1 | GO:0006580 | BP | ethanolamine metabolic process |
| 376 | palevioletred3 | 43 | 2.6e-03 | 1.00 | 1 | GO:0019290 | BP | siderophore biosynthetic process |
| 377 | palevioletred3 | 43 | 2.6e-03 | 1.00 | 1 | GO:0070625 | BP | zymogen granule exocytosis |
| 378 | palevioletred3 | 43 | 2.6e-03 | 1.00 | 1 | GO:0090096 | BP | positive regulation of metanephric cap mesenchymal cell proliferation |
| 379 | palevioletred3 | 43 | 2.6e-03 | 1.00 | 1 | GO:1900062 | BP | regulation of replicative cell aging |
| 380 | palevioletred3 | 43 | 2.6e-03 | 1.00 | 1 | GO:1904681 | BP | response to 3-methylcholanthrene |
| 381 | pink | 453 | 1.4e-04 | 1.00 | 5 | GO:0008329 | MF | signaling pattern recognition receptor activity |
| 382 | pink | 453 | 1.8e-04 | 1.00 | 5 | GO:0038187 | MF | pattern recognition receptor activity |
| 383 | pink | 453 | 2.5e-04 | 1.00 | 3 | GO:0046696 | CC | lipopolysaccharide receptor complex |
| 384 | pink | 453 | 2.5e-04 | 1.00 | 3 | GO:0001875 | MF | lipopolysaccharide receptor activity |
| 385 | pink | 453 | 7.9e-04 | 1.00 | 4 | GO:0009595 | BP | detection of biotic stimulus |
| 386 | pink | 453 | 8.2e-04 | 1.00 | 3 | GO:0035280 | BP | miRNA loading onto RISC involved in gene silencing by miRNA |
| 387 | pink | 453 | 8.7e-04 | 1.00 | 2 | GO:1903527 | BP | positive regulation of membrane tubulation |
| 388 | pink | 453 | 1.9e-03 | 1.00 | 3 | GO:0070922 | BP | small RNA loading onto RISC |
| 389 | pink | 453 | 1.9e-03 | 1.00 | 3 | GO:0070578 | CC | RISC-loading complex |
| 390 | pink | 453 | 2.6e-03 | 1.00 | 3 | GO:0033147 | BP | negative regulation of intracellular estrogen receptor signaling pathway |
| 391 | plum1 | 68 | 3.4e-04 | 1.00 | 6 | GO:0050907 | BP | detection of chemical stimulus involved in sensory perception |
| 392 | plum1 | 68 | 6.6e-04 | 1.00 | 6 | GO:0009593 | BP | detection of chemical stimulus |
| 393 | plum1 | 68 | 6.7e-04 | 1.00 | 4 | GO:0006690 | BP | icosanoid metabolic process |
| 394 | plum1 | 68 | 6.9e-04 | 1.00 | 4 | GO:0001676 | BP | long-chain fatty acid metabolic process |
| 395 | plum1 | 68 | 7.9e-04 | 1.00 | 6 | GO:0007606 | BP | sensory perception of chemical stimulus |
| 396 | plum1 | 68 | 8.1e-04 | 1.00 | 3 | GO:0019369 | BP | arachidonic acid metabolic process |
| 397 | plum1 | 68 | 8.3e-04 | 1.00 | 6 | GO:0050906 | BP | detection of stimulus involved in sensory perception |
| 398 | plum1 | 68 | 9.2e-04 | 1.00 | 9 | GO:0007600 | BP | sensory perception |
| 399 | plum1 | 68 | 1.1e-03 | 1.00 | 5 | GO:0050911 | BP | detection of chemical stimulus involved in sensory perception of smell |
| 400 | plum1 | 68 | 1.1e-03 | 1.00 | 5 | GO:0004984 | MF | olfactory receptor activity |
| 401 | plum2 | 42 | 2.1e-04 | 1.00 | 2 | GO:2000427 | BP | positive regulation of apoptotic cell clearance |
| 402 | plum2 | 42 | 4.1e-04 | 1.00 | 2 | GO:0006957 | BP | complement activation, alternative pathway |
| 403 | plum2 | 42 | 4.9e-04 | 1.00 | 2 | GO:0033004 | BP | negative regulation of mast cell activation |
| 404 | plum2 | 42 | 6.7e-04 | 1.00 | 3 | GO:0019915 | BP | lipid storage |
| 405 | plum2 | 42 | 1.1e-03 | 1.00 | 5 | GO:0051260 | BP | protein homooligomerization |
| 406 | plum2 | 42 | 2.5e-03 | 1.00 | 3 | GO:0072686 | CC | mitotic spindle |
| 407 | plum2 | 42 | 2.8e-03 | 1.00 | 1 | GO:0003195 | BP | tricuspid valve formation |
| 408 | plum2 | 42 | 2.8e-03 | 1.00 | 1 | GO:0032685 | BP | negative regulation of granulocyte macrophage colony-stimulating factor production |
| 409 | plum2 | 42 | 2.8e-03 | 1.00 | 1 | GO:0032701 | BP | negative regulation of interleukin-18 production |
| 410 | plum2 | 42 | 2.8e-03 | 1.00 | 1 | GO:0042431 | BP | indole metabolic process |
| 411 | purple | 366 | 5.7e-05 | 1.00 | 3 | GO:1902031 | BP | regulation of NADP metabolic process |
| 412 | purple | 366 | 6.6e-05 | 1.00 | 4 | GO:1900112 | BP | regulation of histone H3-K9 trimethylation |
| 413 | purple | 366 | 7.3e-05 | 1.00 | 15 | GO:0051054 | BP | positive regulation of DNA metabolic process |
| 414 | purple | 366 | 1.4e-04 | 1.00 | 3 | GO:0042373 | BP | vitamin K metabolic process |
| 415 | purple | 366 | 3.9e-04 | 1.00 | 4 | GO:0036124 | BP | histone H3-K9 trimethylation |
| 416 | purple | 366 | 6.0e-04 | 1.00 | 2 | GO:0043456 | BP | regulation of pentose-phosphate shunt |
| 417 | purple | 366 | 6.3e-04 | 1.00 | 36 | GO:0000278 | BP | mitotic cell cycle |
| 418 | purple | 366 | 7.4e-04 | 1.00 | 3 | GO:0051574 | BP | positive regulation of histone H3-K9 methylation |
| 419 | purple | 366 | 8.2e-04 | 1.00 | 4 | GO:0005719 | CC | nuclear euchromatin |
| 420 | purple | 366 | 1.0e-03 | 1.00 | 4 | GO:0051570 | BP | regulation of histone H3-K9 methylation |
| 421 | red | 551 | 5.6e-05 | 1.00 | 4 | GO:0002517 | BP | T cell tolerance induction |
| 422 | red | 551 | 5.6e-05 | 1.00 | 4 | GO:0002664 | BP | regulation of T cell tolerance induction |
| 423 | red | 551 | 3.3e-04 | 1.00 | 28 | GO:0004674 | MF | protein serine/threonine kinase activity |
| 424 | red | 551 | 4.6e-04 | 1.00 | 3 | GO:0002666 | BP | positive regulation of T cell tolerance induction |
| 425 | red | 551 | 4.6e-04 | 1.00 | 3 | GO:0032714 | BP | negative regulation of interleukin-5 production |
| 426 | red | 551 | 4.6e-04 | 1.00 | 3 | GO:0035650 | MF | AP-1 adaptor complex binding |
| 427 | red | 551 | 5.3e-04 | 1.00 | 6 | GO:0035066 | BP | positive regulation of histone acetylation |
| 428 | red | 551 | 6.4e-04 | 1.00 | 10 | GO:0031058 | BP | positive regulation of histone modification |
| 429 | red | 551 | 6.9e-04 | 1.00 | 4 | GO:0002643 | BP | regulation of tolerance induction |
| 430 | red | 551 | 7.9e-04 | 1.00 | 5 | GO:0030867 | CC | rough endoplasmic reticulum membrane |
| 431 | royalblue | 177 | 5.6e-04 | 1.00 | 3 | GO:0032516 | BP | positive regulation of phosphoprotein phosphatase activity |
| 432 | royalblue | 177 | 6.5e-04 | 1.00 | 10 | GO:0006260 | BP | DNA replication |
| 433 | royalblue | 177 | 7.8e-04 | 1.00 | 11 | GO:0035690 | BP | cellular response to drug |
| 434 | royalblue | 177 | 1.9e-03 | 1.00 | 20 | GO:0006259 | BP | DNA metabolic process |
| 435 | royalblue | 177 | 2.1e-03 | 1.00 | 2 | GO:2001040 | BP | positive regulation of cellular response to drug |
| 436 | royalblue | 177 | 2.2e-03 | 1.00 | 3 | GO:0010664 | BP | negative regulation of striated muscle cell apoptotic process |
| 437 | royalblue | 177 | 2.9e-03 | 1.00 | 3 | GO:0045671 | BP | negative regulation of osteoclast differentiation |
| 438 | royalblue | 177 | 3.2e-03 | 1.00 | 3 | GO:0010922 | BP | positive regulation of phosphatase activity |
| 439 | royalblue | 177 | 4.5e-03 | 1.00 | 3 | GO:0086005 | BP | ventricular cardiac muscle cell action potential |
| 440 | royalblue | 177 | 4.5e-03 | 1.00 | 4 | GO:0016266 | BP | O-glycan processing |
| 441 | saddlebrown | 104 | 1.5e-04 | 1.00 | 2 | GO:0034164 | BP | negative regulation of toll-like receptor 9 signaling pathway |
| 442 | saddlebrown | 104 | 4.8e-04 | 1.00 | 2 | GO:0003339 | BP | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis |
| 443 | saddlebrown | 104 | 1.0e-03 | 1.00 | 2 | GO:0034163 | BP | regulation of toll-like receptor 9 signaling pathway |
| 444 | saddlebrown | 104 | 1.7e-03 | 1.00 | 2 | GO:0003337 | BP | mesenchymal to epithelial transition involved in metanephros morphogenesis |
| 445 | saddlebrown | 104 | 2.1e-03 | 1.00 | 2 | GO:1990907 | CC | beta-catenin-TCF complex |
| 446 | saddlebrown | 104 | 2.1e-03 | 1.00 | 2 | GO:0030280 | MF | structural constituent of epidermis |
| 447 | saddlebrown | 104 | 2.6e-03 | 1.00 | 2 | GO:0034214 | BP | protein hexamerization |
| 448 | saddlebrown | 104 | 2.6e-03 | 1.00 | 2 | GO:0060742 | BP | epithelial cell differentiation involved in prostate gland development |
| 449 | saddlebrown | 104 | 2.6e-03 | 1.00 | 2 | GO:0072182 | BP | regulation of nephron tubule epithelial cell differentiation |
| 450 | saddlebrown | 104 | 2.6e-03 | 1.00 | 2 | GO:0072283 | BP | metanephric renal vesicle morphogenesis |
| 451 | salmon | 272 | 3.2e-04 | 1.00 | 2 | GO:0015860 | BP | purine nucleoside transmembrane transport |
| 452 | salmon | 272 | 3.2e-04 | 1.00 | 2 | GO:0003953 | MF | NAD+ nucleosidase activity |
| 453 | salmon | 272 | 3.2e-04 | 1.00 | 2 | GO:0050135 | MF | NAD(P)+ nucleosidase activity |
| 454 | salmon | 272 | 3.2e-04 | 1.00 | 2 | GO:0061809 | MF | NAD+ nucleotidase, cyclic ADP-ribose generating |
| 455 | salmon | 272 | 6.2e-04 | 1.00 | 3 | GO:0051798 | BP | positive regulation of hair follicle development |
| 456 | salmon | 272 | 8.4e-04 | 1.00 | 3 | GO:0042635 | BP | positive regulation of hair cycle |
| 457 | salmon | 272 | 9.5e-04 | 1.00 | 2 | GO:0019276 | BP | UDP-N-acetylgalactosamine metabolic process |
| 458 | salmon | 272 | 9.5e-04 | 1.00 | 2 | GO:0043316 | BP | cytotoxic T cell degranulation |
| 459 | salmon | 272 | 9.5e-04 | 1.00 | 2 | GO:0005415 | MF | nucleoside:sodium symporter activity |
| 460 | salmon | 272 | 1.1e-03 | 1.00 | 8 | GO:0042737 | BP | drug catabolic process |
| 461 | salmon4 | 39 | 6.0e-05 | 1.00 | 2 | GO:1904528 | BP | positive regulation of microtubule binding |
| 462 | salmon4 | 39 | 2.2e-04 | 1.00 | 2 | GO:0042532 | BP | negative regulation of tyrosine phosphorylation of STAT protein |
| 463 | salmon4 | 39 | 2.2e-04 | 1.00 | 2 | GO:1904526 | BP | regulation of microtubule binding |
| 464 | salmon4 | 39 | 7.1e-04 | 1.00 | 2 | GO:0046426 | BP | negative regulation of JAK-STAT cascade |
| 465 | salmon4 | 39 | 8.1e-04 | 1.00 | 2 | GO:1904893 | BP | negative regulation of STAT cascade |
| 466 | salmon4 | 39 | 2.0e-03 | 1.00 | 2 | GO:0071312 | BP | cellular response to alkaloid |
| 467 | salmon4 | 39 | 2.5e-03 | 1.00 | 1 | GO:0072703 | BP | cellular response to methyl methanesulfonate |
| 468 | salmon4 | 39 | 2.5e-03 | 1.00 | 1 | GO:1901189 | BP | positive regulation of ephrin receptor signaling pathway |
| 469 | salmon4 | 39 | 2.5e-03 | 1.00 | 1 | GO:1901297 | BP | positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment |
| 470 | salmon4 | 39 | 2.5e-03 | 1.00 | 1 | GO:0005880 | CC | nuclear microtubule |
| 471 | sienna3 | 71 | 7.5e-04 | 1.00 | 2 | GO:0034663 | CC | endoplasmic reticulum chaperone complex |
| 472 | sienna3 | 71 | 7.8e-04 | 1.00 | 3 | GO:0033003 | BP | regulation of mast cell activation |
| 473 | sienna3 | 71 | 2.2e-03 | 1.00 | 3 | GO:0045576 | BP | mast cell activation |
| 474 | sienna3 | 71 | 3.5e-03 | 1.00 | 2 | GO:0033005 | BP | positive regulation of mast cell activation |
| 475 | sienna3 | 71 | 4.6e-03 | 1.00 | 1 | GO:0002642 | BP | positive regulation of immunoglobulin biosynthetic process |
| 476 | sienna3 | 71 | 4.6e-03 | 1.00 | 1 | GO:0071529 | BP | cementum mineralization |
| 477 | sienna3 | 71 | 4.6e-03 | 1.00 | 1 | GO:0071654 | BP | positive regulation of chemokine (C-C motif) ligand 1 production |
| 478 | sienna3 | 71 | 4.6e-03 | 1.00 | 1 | GO:0004092 | MF | carnitine O-acetyltransferase activity |
| 479 | sienna3 | 71 | 4.6e-03 | 1.00 | 1 | GO:0008794 | MF | arsenate reductase (glutaredoxin) activity |
| 480 | sienna3 | 71 | 4.6e-03 | 1.00 | 1 | GO:0050633 | MF | acetyl-CoA C-myristoyltransferase activity |
| 481 | skyblue | 106 | 5.0e-05 | 0.90 | 2 | GO:0002169 | CC | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial |
| 482 | skyblue | 106 | 5.0e-05 | 0.90 | 2 | GO:1905202 | CC | methylcrotonoyl-CoA carboxylase complex |
| 483 | skyblue | 106 | 5.0e-05 | 0.90 | 2 | GO:0004485 | MF | methylcrotonoyl-CoA carboxylase activity |
| 484 | skyblue | 106 | 2.9e-04 | 1.00 | 2 | GO:0033132 | BP | negative regulation of glucokinase activity |
| 485 | skyblue | 106 | 7.3e-04 | 1.00 | 2 | GO:0006552 | BP | leucine catabolic process |
| 486 | skyblue | 106 | 7.3e-04 | 1.00 | 2 | GO:0140161 | MF | monocarboxylate:sodium symporter activity |
| 487 | skyblue | 106 | 8.9e-04 | 1.00 | 3 | GO:0032689 | BP | negative regulation of interferon-gamma production |
| 488 | skyblue | 106 | 1.3e-03 | 1.00 | 4 | GO:0001776 | BP | leukocyte homeostasis |
| 489 | skyblue | 106 | 1.7e-03 | 1.00 | 2 | GO:0006768 | BP | biotin metabolic process |
| 490 | skyblue | 106 | 1.7e-03 | 1.00 | 2 | GO:2001198 | BP | regulation of dendritic cell differentiation |
| 491 | skyblue3 | 62 | 1.0e-04 | 1.00 | 2 | GO:1900127 | BP | positive regulation of hyaluronan biosynthetic process |
| 492 | skyblue3 | 62 | 1.3e-03 | 1.00 | 2 | GO:0030213 | BP | hyaluronan biosynthetic process |
| 493 | skyblue3 | 62 | 3.7e-03 | 1.00 | 2 | GO:0050974 | BP | detection of mechanical stimulus involved in sensory perception |
| 494 | skyblue3 | 62 | 4.2e-03 | 1.00 | 1 | GO:0002882 | BP | positive regulation of chronic inflammatory response to non-antigenic stimulus |
| 495 | skyblue3 | 62 | 4.2e-03 | 1.00 | 1 | GO:0003017 | BP | lymph circulation |
| 496 | skyblue3 | 62 | 4.2e-03 | 1.00 | 1 | GO:0033030 | BP | negative regulation of neutrophil apoptotic process |
| 497 | skyblue3 | 62 | 4.2e-03 | 1.00 | 1 | GO:0045083 | BP | negative regulation of interleukin-12 biosynthetic process |
| 498 | skyblue3 | 62 | 4.2e-03 | 1.00 | 1 | GO:0045728 | BP | respiratory burst after phagocytosis |
| 499 | skyblue3 | 62 | 4.2e-03 | 1.00 | 1 | GO:0050976 | BP | detection of mechanical stimulus involved in sensory perception of touch |
| 500 | skyblue3 | 62 | 4.2e-03 | 1.00 | 1 | GO:0072254 | BP | metanephric glomerular mesangial cell differentiation |
| 501 | steelblue | 90 | 4.2e-04 | 1.00 | 7 | GO:0032868 | BP | response to insulin |
| 502 | steelblue | 90 | 7.5e-04 | 1.00 | 6 | GO:0032869 | BP | cellular response to insulin stimulus |
| 503 | steelblue | 90 | 7.8e-04 | 1.00 | 13 | GO:0009725 | BP | response to hormone |
| 504 | steelblue | 90 | 7.9e-04 | 1.00 | 5 | GO:0008286 | BP | insulin receptor signaling pathway |
| 505 | steelblue | 90 | 1.1e-03 | 1.00 | 3 | GO:0000387 | BP | spliceosomal snRNP assembly |
| 506 | steelblue | 90 | 1.2e-03 | 1.00 | 8 | GO:0043434 | BP | response to peptide hormone |
| 507 | steelblue | 90 | 1.4e-03 | 1.00 | 2 | GO:0045945 | BP | positive regulation of transcription by RNA polymerase III |
| 508 | steelblue | 90 | 1.4e-03 | 1.00 | 2 | GO:0000800 | CC | lateral element |
| 509 | steelblue | 90 | 1.4e-03 | 1.00 | 2 | GO:0031588 | CC | nucleotide-activated protein kinase complex |
| 510 | steelblue | 90 | 1.7e-03 | 1.00 | 2 | GO:0010917 | BP | negative regulation of mitochondrial membrane potential |
| 511 | tan | 289 | 3.5e-04 | 1.00 | 2 | GO:0097022 | BP | lymphocyte migration into lymph node |
| 512 | tan | 289 | 5.1e-04 | 1.00 | 3 | GO:0032933 | BP | SREBP signaling pathway |
| 513 | tan | 289 | 7.1e-04 | 1.00 | 3 | GO:0071501 | BP | cellular response to sterol depletion |
| 514 | tan | 289 | 9.7e-04 | 1.00 | 3 | GO:0006991 | BP | response to sterol depletion |
| 515 | tan | 289 | 1.0e-03 | 1.00 | 2 | GO:0003257 | BP | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
| 516 | tan | 289 | 1.0e-03 | 1.00 | 2 | GO:0097021 | BP | lymphocyte migration into lymphoid organs |
| 517 | tan | 289 | 1.0e-03 | 1.00 | 2 | GO:1903292 | BP | protein localization to Golgi membrane |
| 518 | tan | 289 | 1.6e-03 | 1.00 | 7 | GO:0017015 | BP | regulation of transforming growth factor beta receptor signaling pathway |
| 519 | tan | 289 | 2.1e-03 | 1.00 | 2 | GO:0038116 | BP | chemokine (C-C motif) ligand 21 signaling pathway |
| 520 | tan | 289 | 2.1e-03 | 1.00 | 2 | GO:0045541 | BP | negative regulation of cholesterol biosynthetic process |
| 521 | thistle1 | 42 | 2.3e-04 | 1.00 | 3 | GO:0043022 | MF | ribosome binding |
| 522 | thistle1 | 42 | 2.8e-03 | 1.00 | 1 | GO:0050668 | BP | positive regulation of homocysteine metabolic process |
| 523 | thistle1 | 42 | 2.8e-03 | 1.00 | 1 | GO:0072755 | BP | cellular response to benomyl |
| 524 | thistle1 | 42 | 2.8e-03 | 1.00 | 1 | GO:0004852 | MF | uroporphyrinogen-III synthase activity |
| 525 | thistle1 | 42 | 3.5e-03 | 1.00 | 3 | GO:0043021 | MF | ribonucleoprotein complex binding |
| 526 | thistle1 | 42 | 5.7e-03 | 1.00 | 1 | GO:0006780 | BP | uroporphyrinogen III biosynthetic process |
| 527 | thistle1 | 42 | 5.7e-03 | 1.00 | 1 | GO:0016036 | BP | cellular response to phosphate starvation |
| 528 | thistle1 | 42 | 5.7e-03 | 1.00 | 1 | GO:0050666 | BP | regulation of homocysteine metabolic process |
| 529 | thistle1 | 42 | 5.7e-03 | 1.00 | 1 | GO:0060733 | BP | regulation of eIF2 alpha phosphorylation by amino acid starvation |
| 530 | thistle1 | 42 | 5.7e-03 | 1.00 | 1 | GO:0070541 | BP | response to platinum ion |
| 531 | thistle2 | 35 | 2.4e-03 | 1.00 | 1 | GO:0006185 | BP | dGDP biosynthetic process |
| 532 | thistle2 | 35 | 2.4e-03 | 1.00 | 1 | GO:0046054 | BP | dGMP metabolic process |
| 533 | thistle2 | 35 | 2.4e-03 | 1.00 | 1 | GO:0046711 | BP | GDP biosynthetic process |
| 534 | thistle2 | 35 | 2.4e-03 | 1.00 | 1 | GO:0032440 | MF | 2-alkenal reductase [NAD(P)] activity |
| 535 | thistle2 | 35 | 2.4e-03 | 1.00 | 1 | GO:0047323 | MF | [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity |
| 536 | thistle2 | 35 | 2.4e-03 | 1.00 | 1 | GO:0050262 | MF | ribosylnicotinamide kinase activity |
| 537 | thistle2 | 35 | 2.4e-03 | 1.00 | 1 | GO:0061769 | MF | ribosylnicotinate kinase activity |
| 538 | thistle2 | 35 | 3.4e-03 | 1.00 | 3 | GO:0007519 | BP | skeletal muscle tissue development |
| 539 | thistle2 | 35 | 4.0e-03 | 1.00 | 3 | GO:0060538 | BP | skeletal muscle organ development |
| 540 | thistle2 | 35 | 4.8e-03 | 1.00 | 1 | GO:0008418 | MF | protein-N-terminal asparagine amidohydrolase activity |
| 541 | turquoise | 3700 | 8.1e-04 | 1.00 | 9 | GO:2000353 | BP | positive regulation of endothelial cell apoptotic process |
| 542 | turquoise | 3700 | 1.1e-03 | 1.00 | 7 | GO:0097104 | BP | postsynaptic membrane assembly |
| 543 | turquoise | 3700 | 1.6e-03 | 1.00 | 13 | GO:1904037 | BP | positive regulation of epithelial cell apoptotic process |
| 544 | turquoise | 3700 | 1.7e-03 | 1.00 | 58 | GO:0051168 | BP | nuclear export |
| 545 | turquoise | 3700 | 1.8e-03 | 1.00 | 11 | GO:0090140 | BP | regulation of mitochondrial fission |
| 546 | turquoise | 3700 | 1.8e-03 | 1.00 | 54 | GO:0006611 | BP | protein export from nucleus |
| 547 | turquoise | 3700 | 2.9e-03 | 1.00 | 14 | GO:0071709 | BP | membrane assembly |
| 548 | turquoise | 3700 | 3.0e-03 | 1.00 | 7 | GO:0018095 | BP | protein polyglutamylation |
| 549 | turquoise | 3700 | 3.5e-03 | 1.00 | 18 | GO:0007080 | BP | mitotic metaphase plate congression |
| 550 | turquoise | 3700 | 3.5e-03 | 1.00 | 4 | GO:0002605 | BP | negative regulation of dendritic cell antigen processing and presentation |
| 551 | violet | 77 | 2.6e-05 | 0.47 | 2 | GO:0001300 | BP | chronological cell aging |
| 552 | violet | 77 | 4.8e-04 | 1.00 | 4 | GO:0071260 | BP | cellular response to mechanical stimulus |
| 553 | violet | 77 | 1.1e-03 | 1.00 | 2 | GO:0060433 | BP | bronchus development |
| 554 | violet | 77 | 1.2e-03 | 1.00 | 3 | GO:0035094 | BP | response to nicotine |
| 555 | violet | 77 | 1.3e-03 | 1.00 | 3 | GO:0030858 | BP | positive regulation of epithelial cell differentiation |
| 556 | violet | 77 | 1.7e-03 | 1.00 | 2 | GO:0034236 | MF | protein kinase A catalytic subunit binding |
| 557 | violet | 77 | 2.1e-03 | 1.00 | 5 | GO:0060348 | BP | bone development |
| 558 | violet | 77 | 3.4e-03 | 1.00 | 2 | GO:0048745 | BP | smooth muscle tissue development |
| 559 | violet | 77 | 3.8e-03 | 1.00 | 2 | GO:0030277 | BP | maintenance of gastrointestinal epithelium |
| 560 | violet | 77 | 4.3e-03 | 1.00 | 3 | GO:0030279 | BP | negative regulation of ossification |
| 561 | white | 124 | 1.2e-04 | 1.00 | 7 | GO:2001242 | BP | regulation of intrinsic apoptotic signaling pathway |
| 562 | white | 124 | 2.1e-04 | 1.00 | 4 | GO:2000107 | BP | negative regulation of leukocyte apoptotic process |
| 563 | white | 124 | 6.5e-04 | 1.00 | 3 | GO:1902175 | BP | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
| 564 | white | 124 | 7.2e-04 | 1.00 | 5 | GO:2001243 | BP | negative regulation of intrinsic apoptotic signaling pathway |
| 565 | white | 124 | 7.4e-04 | 1.00 | 9 | GO:0043687 | BP | post-translational protein modification |
| 566 | white | 124 | 9.9e-04 | 1.00 | 2 | GO:0007354 | BP | zygotic determination of anterior/posterior axis, embryo |
| 567 | white | 124 | 1.0e-03 | 1.00 | 10 | GO:0022613 | BP | ribonucleoprotein complex biogenesis |
| 568 | white | 124 | 1.4e-03 | 1.00 | 2 | GO:0045236 | MF | CXCR chemokine receptor binding |
| 569 | white | 124 | 1.8e-03 | 1.00 | 4 | GO:2001021 | BP | negative regulation of response to DNA damage stimulus |
| 570 | white | 124 | 1.8e-03 | 1.00 | 2 | GO:0000052 | BP | citrulline metabolic process |
| 571 | yellow | 631 | 4.2e-05 | 0.77 | 12 | GO:0030838 | BP | positive regulation of actin filament polymerization |
| 572 | yellow | 631 | 4.8e-05 | 0.88 | 17 | GO:0030832 | BP | regulation of actin filament length |
| 573 | yellow | 631 | 5.0e-05 | 0.91 | 16 | GO:0030833 | BP | regulation of actin filament polymerization |
| 574 | yellow | 631 | 6.4e-05 | 1.00 | 17 | GO:0030041 | BP | actin filament polymerization |
| 575 | yellow | 631 | 6.8e-05 | 1.00 | 14 | GO:0032273 | BP | positive regulation of protein polymerization |
| 576 | yellow | 631 | 8.8e-05 | 1.00 | 4 | GO:1901620 | BP | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning |
| 577 | yellow | 631 | 1.5e-04 | 1.00 | 16 | GO:0008064 | BP | regulation of actin polymerization or depolymerization |
| 578 | yellow | 631 | 1.7e-04 | 1.00 | 12 | GO:0031532 | BP | actin cytoskeleton reorganization |
| 579 | yellow | 631 | 2.0e-04 | 1.00 | 40 | GO:0030036 | BP | actin cytoskeleton organization |
| 580 | yellow | 631 | 2.0e-04 | 1.00 | 44 | GO:0030029 | BP | actin filament-based process |
| 581 | yellowgreen | 69 | 4.1e-04 | 1.00 | 2 | GO:0042780 | BP | tRNA 3’-end processing |
| 582 | yellowgreen | 69 | 6.6e-04 | 1.00 | 49 | GO:0006807 | BP | nitrogen compound metabolic process |
| 583 | yellowgreen | 69 | 1.6e-03 | 1.00 | 50 | GO:0044237 | BP | cellular metabolic process |
| 584 | yellowgreen | 69 | 1.8e-03 | 1.00 | 2 | GO:0099116 | BP | tRNA 5’-end processing |
| 585 | yellowgreen | 69 | 2.0e-03 | 1.00 | 2 | GO:0051580 | BP | regulation of neurotransmitter uptake |
| 586 | yellowgreen | 69 | 2.1e-03 | 1.00 | 4 | GO:0031123 | BP | RNA 3’-end processing |
| 587 | yellowgreen | 69 | 2.3e-03 | 1.00 | 2 | GO:0098810 | BP | neurotransmitter reuptake |
| 588 | yellowgreen | 69 | 2.7e-03 | 1.00 | 3 | GO:0031490 | MF | chromatin DNA binding |
| 589 | yellowgreen | 69 | 3.0e-03 | 1.00 | 17 | GO:0016740 | MF | transferase activity |
| 590 | yellowgreen | 69 | 3.3e-03 | 1.00 | 2 | GO:0000966 | BP | RNA 5’-end processing |
Factors de transcripció tots els mòduls associats
Els mòduls no son signidicatius (p>0.05 i <0.1)